Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Clinical Immunology
Published in: Journal of Clinical Immunology 5/2003

01-09-2003

Identification of an HLA-A0201-Restricted CTL Epitope Generated by a Tumor-Specific Frameshift Mutation in a Coding Microsatellite of the OGT Gene

Authors: Eva Ripberger, Michael Linnebacher, Yvette Schwitalle, Johannes Gebert, Magnus Von Knebel Doeberitz

Published in: Journal of Clinical Immunology | Issue 5/2003

Login to get access
Metadata
Title
Identification of an HLA-A0201-Restricted CTL Epitope Generated by a Tumor-Specific Frameshift Mutation in a Coding Microsatellite of the OGT Gene
Authors
Eva Ripberger
Michael Linnebacher
Yvette Schwitalle
Johannes Gebert
Magnus Von Knebel Doeberitz
Publication date
01-09-2003
Publisher
Kluwer Academic Publishers-Plenum Publishers
Published in
Journal of Clinical Immunology / Issue 5/2003
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1023/A:1025329819121

Other articles of this Issue 5/2003

Journal of Clinical Immunology 5/2003 Go to the issue

OriginalPaper

Reduced IFN-γ Responses Associated with HLA-DR15 Presentation of Streptococcal Cell Wall Proteins to Dermal Th-1 Cells in Psoriasis

OriginalPaper

The “Fuzzy Logic” of the Death-Inducing Signaling Complex in Lymphocytes

OriginalPaper

Increased Interleukin-7 Plasma Levels Are Associated with Recovery of CD4+ T Cells in HIV-Infected Children

OriginalPaper

Upregulation of Neurokinin-1 Receptor Expression in the Lungs of Patients with Sarcoidosis

OriginalPaper

Common Variable Immunodeficiency Patient Classification Based on Impaired B Cell Memory Differentiation Correlates with Clinical Aspects

OriginalPaper

Prevalence and Clinical Correlations of Antibodies Against Six β2-Glycoprotein-I-Related Peptides in the Antiphospholipid Syndrome
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits